Uges DR - Search Results

1

A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance.

Hospers GA, Meijer C, de Leij L, Uges DR, Mulder NH, de Vries EG. Hospers GA, et al. Among authors: uges dr. Int J Cancer. 1990 Jul 15;46(1):138-44. doi: 10.1002/ijc.2910460125. Int J Cancer. 1990. PMID: 2163989

2

In vitro and in vivo modulation of multi-drug resistance with amiodarone.

van der Graaf WT, de Vries EG, Uges DR, Nanninga AG, Meijer C, Vellenga E, Mulder PO, Mulder NH. van der Graaf WT, et al. Among authors: uges dr. Int J Cancer. 1991 Jun 19;48(4):616-22. doi: 10.1002/ijc.2910480422. Int J Cancer. 1991. PMID: 1646180

3

Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive days.

Mulder PO, de Vries EG, Uges DR, Scaf AH, Sleijfer DT, Mulder NH. Mulder PO, et al. Among authors: uges dr. Br J Cancer. 1990 Mar;61(3):460-4. doi: 10.1038/bjc.1990.101. Br J Cancer. 1990. PMID: 2183874 Free PMC article.

4

The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.

Meijer C, Mulder NH, Hospers GA, Uges DR, de Vries EG. Meijer C, et al. Among authors: uges dr. Br J Cancer. 1990 Jul;62(1):72-7. doi: 10.1038/bjc.1990.232. Br J Cancer. 1990. PMID: 2390486 Free PMC article.

5

Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line.

Timmer-Bosscha H, Hospers GA, Meijer C, Mulder NH, Muskiet FA, Martini IA, Uges DR, de Vries EG. Timmer-Bosscha H, et al. Among authors: uges dr. J Natl Cancer Inst. 1989 Jul 19;81(14):1069-75. doi: 10.1093/jnci/81.14.1069. J Natl Cancer Inst. 1989. PMID: 2544740

6

Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.

Hospers GA, Mulder NH, de Jong B, de Ley L, Uges DR, Fichtinger-Schepman AM, Scheper RJ, de Vries EG. Hospers GA, et al. Among authors: uges dr. Cancer Res. 1988 Dec 1;48(23):6803-7. Cancer Res. 1988. PMID: 2846161

7

Renal dysfunction following high-dose carboplatin treatment.

Mulder PO, Sleijfer DT, de Vries EG, Uges DR, Mulder NH. Mulder PO, et al. Among authors: uges dr. J Cancer Res Clin Oncol. 1988;114(2):212-4. doi: 10.1007/BF00417840. J Cancer Res Clin Oncol. 1988. PMID: 3280573

8

Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: a phase I and pharmacokinetic study.

Groen HJ, van der Leest AH, de Vries EG, Uges DR, Szabó BG, Mulder NH. Groen HJ, et al. Among authors: uges dr. Br J Cancer. 1995 Oct;72(4):992-7. doi: 10.1038/bjc.1995.448. Br J Cancer. 1995. PMID: 7547255 Free PMC article. Clinical Trial.

9

Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.

Sark MW, Timmer-Bosscha H, Meijer C, Uges DR, Sluiter WJ, Peters WH, Mulder NH, de Vries EG. Sark MW, et al. Among authors: uges dr. Br J Cancer. 1995 Apr;71(4):684-90. doi: 10.1038/bjc.1995.135. Br J Cancer. 1995. PMID: 7710929 Free PMC article.

10

Effect of ultrafilterable platinum concentration on cisplatin and carboplatin cytotoxicity in human tumor and bone marrow cells in vitro.

Guchelaar HJ, de Vries EG, Meijer C, Esselink MT, Vellenga E, Uges DR, Mulder NH. Guchelaar HJ, et al. Among authors: uges dr. Pharm Res. 1994 Sep;11(9):1265-9. doi: 10.1023/a:1018934209719. Pharm Res. 1994. PMID: 7816754

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters